Bavarian Nordic A/S
Bavarian Nordic A/S
11/07/2025 | Press release | Distributed by Public on 11/07/2025 10:33
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
Danish English Published: 2025-11-07 17:30:00 CET Bavarian Nordic A/S - Major shareholder announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
COPENHAGEN, Denmark, November 7, 2025 - Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5,13% of the shares and voting rights in Bavarian Nordic A/S as of October 31, 2025.
About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit https://www.bavarian-nordic.com.
Contact investors:Europe: Disa Tuominen, IR Manager, [email protected]: Graham Morrell, Gilmartin Group, [email protected], Tel: +1 781 686 9600
Contact media:Nicole Seroff, Vice President Corporate Communications, [email protected], Tel: +45 53 88 06 03
Company Announcement no. 41 / 2025
Attachment
- Company Announcement no. 41 / 2025
2025-41-en.pdf https://attachment.news.eu.nasdaq.com/a79acd736915153787559967eb61b699f
Company News Subscribe European Market Activity Nasdaq Europe
© 2025, Nasdaq, Inc. All Rights Reserved.
Bavarian Nordic A/S published this content on November 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 07, 2025 at 16:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]